Annual EBITDA
-$36.98 M
+$17.81 M+32.50%
December 31, 2021
Summary
- As of February 10, 2025, YMTX annual EBITDA is -$36.98 million, with the most recent change of +$17.81 million (+32.50%) on December 31, 2021.
- During the last 3 years, YMTX annual EBITDA has fallen by -$8.04 million (-27.77%).
Performance
YMTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$3.35 M
+$1.46 M+30.27%
September 30, 2022
Summary
- As of February 10, 2025, YMTX quarterly EBITDA is -$3.35 million, with the most recent change of +$1.46 million (+30.27%) on September 30, 2022.
- Over the past year, YMTX quarterly EBITDA has increased by +$6.01 million (+64.20%).
Performance
YMTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$30.80 M
+$6.01 M+16.33%
September 30, 2022
Summary
- As of February 10, 2025, YMTX TTM EBITDA is -$30.80 million, with the most recent change of +$6.01 million (+16.33%) on September 30, 2022.
- Over the past year, YMTX TTM EBITDA has increased by +$32.24 million (+51.14%).
Performance
YMTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
YMTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +32.5% | +64.2% | +51.1% |
| 3 y3 years | -27.8% | +50.8% | -352.1% |
| 5 y5 years | -27.8% | +50.8% | -352.1% |
YMTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | +279.9% | at high | +35.6% |
| 5 y | 5-year | +27.8% | +48.2% | at high | +972.6% | +352.1% | +104.7% |
| alltime | all time | +27.8% | +48.2% | at high | +972.6% | +352.1% | +104.7% |
Yumanity Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$3.35 M(-30.3%) | -$30.80 M(-16.3%) |
| Jun 2022 | - | -$4.81 M(-62.2%) | -$36.81 M(-11.8%) |
| Mar 2022 | - | -$12.73 M(+28.6%) | -$41.75 M(+12.9%) |
| Dec 2021 | -$36.98 M | -$9.90 M(+5.8%) | -$36.98 M(-41.3%) |
| Sep 2021 | - | -$9.36 M(-4.0%) | -$63.03 M(+6.2%) |
| Jun 2021 | - | -$9.75 M(+22.4%) | -$59.34 M(+6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$7.96 M(-77.8%) | -$55.92 M(+2.1%) |
| Dec 2020 | -$54.79 M(+89.3%) | -$35.95 M(+534.0%) | -$54.77 M(+191.1%) |
| Sep 2020 | - | -$5.67 M(-10.4%) | -$18.81 M(+43.2%) |
| Jun 2020 | - | -$6.33 M(-7.1%) | -$13.14 M(+92.9%) |
| Mar 2020 | - | -$6.81 M | -$6.81 M |
| Dec 2019 | -$28.94 M | - | - |
FAQ
- What is Yumanity Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Yumanity Therapeutics?
- What is Yumanity Therapeutics annual EBITDA year-on-year change?
- What is Yumanity Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Yumanity Therapeutics?
- What is Yumanity Therapeutics quarterly EBITDA year-on-year change?
- What is Yumanity Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Yumanity Therapeutics?
- What is Yumanity Therapeutics TTM EBITDA year-on-year change?
What is Yumanity Therapeutics annual EBITDA?
The current annual EBITDA of YMTX is -$36.98 M
What is the all time high annual EBITDA for Yumanity Therapeutics?
Yumanity Therapeutics all-time high annual EBITDA is -$28.94 M
What is Yumanity Therapeutics annual EBITDA year-on-year change?
Over the past year, YMTX annual EBITDA has changed by +$17.81 M (+32.50%)
What is Yumanity Therapeutics quarterly EBITDA?
The current quarterly EBITDA of YMTX is -$3.35 M
What is the all time high quarterly EBITDA for Yumanity Therapeutics?
Yumanity Therapeutics all-time high quarterly EBITDA is -$3.35 M
What is Yumanity Therapeutics quarterly EBITDA year-on-year change?
Over the past year, YMTX quarterly EBITDA has changed by +$6.01 M (+64.20%)
What is Yumanity Therapeutics TTM EBITDA?
The current TTM EBITDA of YMTX is -$30.80 M
What is the all time high TTM EBITDA for Yumanity Therapeutics?
Yumanity Therapeutics all-time high TTM EBITDA is -$6.81 M
What is Yumanity Therapeutics TTM EBITDA year-on-year change?
Over the past year, YMTX TTM EBITDA has changed by +$32.24 M (+51.14%)